Tellurium-driven maple leaf-shaped manganese nanotherapeutics reshape tumor microenvironment via chemical transition in situ to achieve highly efficient radioimmunotherapy of triple negative breast cancer

Wei Huang,Sujiang Shi,Haoran Lv,Zhenyu Ju,Qinghua Liu,Tianfeng Chen
DOI: https://doi.org/10.1016/j.bioactmat.2023.04.010
IF: 18.9
2023-05-14
Bioactive Materials
Abstract:Highlights • Driven by Te, maple leaf-shaped MnCO 3 @Te were fabricated. • MnCO 3 @Te as an agonist to enhanced radioimmunotherapy. The therapeutic efficacy of radioimmunotherapy against triple negative breast cancer (TNBC) is largely limited by the complicated tumor microenvironment (TME) and its immunosuppressive state. Thus developing a strategy to reshape TME is expected to achieve highly efficient radioimmunotherapy. Therefore, we designed and synthesized a tellurium (Te)-driven maple leaf manganese carbonate nanotherapeutics (MnCO 3 @Te) by gas diffusion method, but also provided a chemical catalytic strategy in situ to augment ROS level and activate immune cells for improving cancer radioimmunotherapy. As expected, with the help of H 2 O 2 in TEM, MnCO 3 @Te heterostructure with reversible Mn 3+ /Mn 2+ transition could catalyze the intracellular ROS overproduction to amplify radiotherapy. In addition, by virtue of the ability to scavenge H + in TME by carbonate group, MnCO 3 @Te directly promote the maturation of dendritic cells and macrophage M1 repolarization by stimulator of interferon genes (STING) pathway activation, resulting in remodeling immuno-microenvironment. As a result, MnCO 3 @Te synergized with radiotherapy and immune checkpoint blockade therapy effectively inhibited the breast cancer growth and lung metastasis in vivo . Collectively, these findings indicate that MnCO 3 @Te as an agonist, successfully overcome radioresistance and awaken immune systems, showing promising potential for solid tumor radioimmunotherapy.
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?